SPAC922.07c Antibody
Description
Antibody Structure and Function
Antibodies (immunoglobulins) are Y-shaped glycoproteins composed of two heavy chains and two light chains, with a flexible hinge region linking the antigen-binding Fab fragments and the effector-binding Fc region .
| Region | Function | Key Features |
|---|---|---|
| Fab | Antigen binding | Contains variable (V) domains that form paratopes (antigen-binding sites) |
| Fc | Effector activation | Interacts with Fc receptors and complement proteins to mediate immune responses |
Clinical Applications of Antibodies
Monoclonal antibodies like LY-CoV555 (used against SARS-CoV-2) demonstrate efficacy in reducing viral load and preventing hospitalization . Their structure includes variable regions targeting specific epitopes and Fc regions optimized for immune effector engagement .
| Antibody Type | Target | Application |
|---|---|---|
| IgG1 (e.g., JC7) | SARS-CoV-2 S2 subunit | ELISA, Western blot |
| IgG (LY-CoV555) | SARS-CoV-2 spike | COVID-19 therapy |
Limitations in Antibody Development
-
SPAC922.07c Antibody is not mentioned in any of the provided sources, suggesting it may be a novel or proprietary compound.
-
Without specific data, its epitope, isotype, or therapeutic target cannot be determined.
Recommendations for Further Research
To generate a detailed profile of SPAC922.07c Antibody, additional sources such as:
-
Peer-reviewed publications (e.g., PubMed, ScienceDirect).
-
Clinical trial registries (e.g., ClinicalTrials.gov).
-
Manufacturer websites or product datasheets.
Product Specs
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Target Background
KEGG: spo:SPAC922.07c
STRING: 4896.SPAC922.07c.1
